Peter Jeffrey Conn
Direktor/Vorstandsmitglied bei Appello Pharmaceuticals, Inc.
Profil
Peter Jeffrey Conn is the founder of Karuna Therapeutics, Inc. which was founded in 2009.
Currently, he holds a position as a Director at Appello Pharmaceuticals, Inc.
Aktive Positionen von Peter Jeffrey Conn
| Unternehmen | Position | Beginn |
|---|---|---|
Appello Pharmaceuticals, Inc.
 Appello Pharmaceuticals, Inc. BiotechnologyHealth Technology Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Peter Jeffrey Conn
| Unternehmen | Position | Ende |
|---|---|---|
| KARA THER | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA. | Health Technology |
Appello Pharmaceuticals, Inc.
Appello Pharmaceuticals, Inc. BiotechnologyHealth Technology Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN. | Health Technology |